Breaking News Instant updates and real-time market news.

ASH

Ashland

$77.77 /

-0.64 (-0.82%)

17:03
07/17/19
07/17
17:03
07/17/19
17:03

Ashland sees Q3 EPS 76c-78c, consensus 86c

Sees Q3 adjusted EBITDA $138M-$142M. The company says that in Q3 "lower-than-anticipated sales in personal care and certain industrial end markets within Specialty Ingredients led to weaker-than-expected results for Ashland. In this context, production volumes were reduced to match demand."

  • 15

    Aug

  • 16

    Aug

ASH Ashland
$77.77 /

-0.64 (-0.82%)

07/12/19 Credit Suisse
Credit Suisse says long-term bull thesis on Ashland 'intact'
06/14/19
Fly Intel: Top five analyst downgrades
06/14/19 JPMorgan
Ashland downgraded to Neutral on valuation at JPMorgan
06/14/19 JPMorgan
Ashland downgraded to Neutral from Overweight at JPMorgan

TODAY'S FREE FLY STORIES

Conference/Events
Society for Pediatric Dermatology to hold virtual meeting » 04:55
07/11/20
07/11
04:55
07/11/20
04:55
ABEO

Abeona Therapeutics

$3.01 /

-0.34 (-10.15%)

, AMGN

Amgen

$249.23 /

-2.03 (-0.81%)

, DRMT

Dermavant

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.02 /

-0.3 (-0.34%)

, PFE

Pfizer

$33.84 /

+0.39 (+1.17%)

, SNY

Sanofi

$50.32 /

-0.24 (-0.47%)

, VRCA

Verrica Pharmaceuticals

$9.51 /

+0.75 (+8.56%)

45th Annual Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

DRMT Dermavant
$0.00 /

+ (+0.00%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

06/05/20 Cantor Fitzgerald
Abeona could trade higher on Lysogene clinical hold, says Cantor Fitzgerald
05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
AMGN Amgen
$249.23 /

-2.03 (-0.81%)

07/02/20 Citi
Citi sees 'considerable amount of investor interest' coming back to Amgen
07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Mizuho
Amgen patent win worth $5-$12 per share, says Mizuho
07/01/20 Goldman Sachs
Court ruling removes overhang for Amgen, says Goldman Sachs
DRMT Dermavant
$0.00 /

+ (+0.00%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
PFE Pfizer
$33.84 /

+0.39 (+1.17%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
SNY Sanofi
$50.32 /

-0.24 (-0.47%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
03/24/20 Needham
Verrica Pharmaceuticals initiated with a Buy at Needham
ABEO Abeona Therapeutics
$3.01 /

-0.34 (-10.15%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

  • 20
    Dec
AMGN Amgen
$249.23 /

-2.03 (-0.81%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

VRCA Verrica Pharmaceuticals
$9.51 /

+0.75 (+8.56%)

AMGN Amgen
$249.23 /

-2.03 (-0.81%)

NVS Novartis
$87.02 /

-0.3 (-0.34%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SNY Sanofi
$50.32 /

-0.24 (-0.47%)

Periodicals
Exxon Mobil resumes drilling in Guyana, Bloomberg reports » 18:51
07/10/20
07/10
18:51
07/10/20
18:51
XOM

Exxon Mobil

$42.66 /

+1.315 (+3.18%)

, BKR

Baker Hughes

$15.06 /

+0.41 (+2.80%)

Exxon Mobil (XOM) resumed…

Exxon Mobil (XOM) resumed drilling in Guyana in June, underscoring its dedication to the area despite the oil price crash and a messy turn in local politics, Bloomberg's Peter Millard and Kevin Crowley report. Two of Exxon's four drillships went back to work, according to data published Friday by Baker Hughes (BKR). The company later confirmed that the Stena Carron and Noble Tom Madden vessels returned to full operations last month. The rigs had been shut when Guyana closed its borders after the pandemic hit South America. Reference Link

ShowHide Related Items >><<
XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
05/13/20 Redburn
Exxon Mobil upgraded to Neutral from Sell at Redburn
05/04/20 Credit Suisse
Exxon Mobil price target raised to $45 from $37 at Credit Suisse
BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

05/29/20 Northland
Baker Hughes initiated with a Market Perform at Northland
04/23/20 Citi
Baker Hughes price target raised to $16 from $14 at Citi
04/05/20 Bernstein
Baker Hughes upgraded to Outperform from Underperform at Bernstein
03/31/20
Fly Intel: Top five analyst downgrades
XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

XOM Exxon Mobil
$42.66 /

+1.315 (+3.18%)

BKR Baker Hughes
$15.06 /

+0.41 (+2.80%)

Periodicals
Atlanta Mayor to pull COVID-19 reopening back to phase 1, CNBC reports » 17:45
07/10/20
07/10
17:45
07/10/20
17:45
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$317.65 /

+3.22 (+1.02%)

In Atlanta, Phase 1…

In Atlanta, Phase 1 involvings staying at home, with essential travel only, according to CNBC.

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Periodicals
Boeing scrambling to gather financing for 737 MAX, Reuters says » 17:44
07/10/20
07/10
17:44
07/10/20
17:44
BA

Boeing

$178.45 /

+5.225 (+3.02%)

Boeing is scrambling to…

Boeing is scrambling to gather financing for the 737 MAX as it awaits regulatory clearance for design changes after the aircraft was grounded following two deadly crashes, Reuters' Tracy Rucinski and Tim Hepher report, citing industry sources. Boeing is seeking to resume deliveries once regulators say it is safe and airlines agree on training, but confidence in the 737 MAX has been harmed by the grounding, making the financing required to ensure smooth deliveries scarce and compounding a lack in demand due to the COVID-19 pandemic, the authors note. "Nobody wants to take new aircraft and this is particularly true for the MAX right now," a senior aviation financier said, according to Reuters. Reference Link

ShowHide Related Items >><<
BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

07/09/20
Emirates tells Bloomberg Boeing 777X likely to miss 2021 debut
07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
06/26/20
Fly Intel: Top five analyst downgrades
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

Hot Stocks
Harte-Hanks announces suspension of trading, commences delisting procedures » 17:42
07/10/20
07/10
17:42
07/10/20
17:42
HHS

Harte-Hanks

$2.75 /

-0.22 (-7.41%)

Harte Hanks announced the…

Harte Hanks announced the company was notified by the NYSE on July 9 that the NYSE had determined to commence proceedings to delist the company's common stock as a result of the company's failure to comply with the continued listing standard to maintain either (i) at least $50M in stockholders' equity or (ii) at least $50M in total market capitalization on a 30-trading day average basis. While the company has the ability to appeal the decision by the NYSE, Harte Hanks' board has determined that it is in the best interest of the company and its shareholders to immediately begin trading on the OTCQX Best Market. The company will remain subject to the public reporting requirements of the SEC following the transfer to the OTCQX and expects the common stock will trade under the symbol "HRTE". The transition to the over-the-counter markets will not affect the company's business operations.

ShowHide Related Items >><<
HHS Harte-Hanks
$2.75 /

-0.22 (-7.41%)

Hot Stocks
Tesla says 2020 annual meeting holders may also attend Battery Day presentation » 17:39
07/10/20
07/10
17:39
07/10/20
17:39
TSLA

Tesla

$1,547.54 /

+153.99 (+11.05%)

Tesla announced that its…

Tesla announced that its 2020 Annual Meeting of Stockholders will be held in person on Tuesday, September 22, 2020, at 2:30 p.m. Pacific Time, at Tesla's Fremont Factory located at 45500 Fremont Blvd, Fremont, CA 94538. Eligible stockholders may also attend Tesla's separate Battery Day presentation, which will be held on the same day, with additional details to be announced at a later time. No formal stockholder business will be conducted at such presentation. Tesla intends to webcast both events live.

ShowHide Related Items >><<
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

07/09/20 Wedbush
China growth story worth $400/share in a bull case to Tesla, says Wedbush
07/07/20 Morgan Stanley
Morgan Stanley raises Tesla price target to $740 with new bull case of $2,070
07/07/20 Barclays
Tesla bears should 'remain in the shelter,' says Barclays
07/06/20 JMP Securities
Tesla price target raised to $1,500 from $1,050 at JMP Securities
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

  • 14
    Feb
TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

TSLA Tesla
$1,547.54 /

+153.99 (+11.05%)

Hot Stocks
W&T Offshore CEO buys 346K shares of common stock » 17:33
07/10/20
07/10
17:33
07/10/20
17:33
WTI

W&T Offshore

$2.31 /

+0.155 (+7.21%)

In a regulatory filing,…

In a regulatory filing, W&T Offshore disclosed that its CEO Tracy Krohn bought 346,358 shares of common stock on July 8th in a transaction total of $740K.

ShowHide Related Items >><<
WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

04/17/20 Roth Capital
W&T Offshore upgraded to Buy from Neutral at Roth Capital
03/13/20 Roth Capital
W&T Offshore downgraded to Neutral from Buy at Roth Capital
03/09/20 Stifel
W&T Offshore downgraded to Hold from Buy at Stifel
WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

WTI W&T Offshore
$2.31 /

+0.155 (+7.21%)

Syndicate
Amyris files to sell 65.2M shares of common stock for holders  17:28
07/10/20
07/10
17:28
07/10/20
17:28
AMRS

Amyris

$4.42 /

+0.06 (+1.38%)

 
ShowHide Related Items >><<
AMRS Amyris
$4.42 /

+0.06 (+1.38%)

AMRS Amyris
$4.42 /

+0.06 (+1.38%)

12/12/19
Fly Intel: Top five analyst initiations
12/12/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer with $8 price target
12/11/19 Oppenheimer
Amyris initiated with an Outperform at Oppenheimer
AMRS Amyris
$4.42 /

+0.06 (+1.38%)

AMRS Amyris
$4.42 /

+0.06 (+1.38%)

AMRS Amyris
$4.42 /

+0.06 (+1.38%)

Hot Stocks
Boeing awarded $150M Missile Defense Agency contract modification » 17:25
07/10/20
07/10
17:25
07/10/20
17:25
BA

Boeing

$178.45 /

+5.225 (+3.02%)

Boeing was awarded a…

Boeing was awarded a $150M undefinitized contract modification to a previously awarded on the ground-based midcourse defense development and sustainment contract, or DSC. The scope of work under the current DSC includes development, fielding, test, systems engineering, integration and configuration management, equipment manufacturing and refurbishment, training and operations and sustainment for the ground-based midcourse defense weapon system and associated support facilities. Under this undefinitized modification, the Missile Defense Agency executes the procurement of four additional configuration 2 ground based interceptor boost vehicles to maintain the fleet and flight test programs. The value of this contract, including options, is increased from $11.34B to $11.49B. The work will be performed in Chandler, Arizona, and the period of performance is from July 10 to July 30, 2023. This acquisition was executed on a sole-source basis. FY20 procurement funds in the amount of in the amount of $72M have been obligated at the time of award. The Missile Defense Agency is the contracting activity.

ShowHide Related Items >><<
BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

07/09/20
Emirates tells Bloomberg Boeing 777X likely to miss 2021 debut
07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
06/26/20
Fly Intel: Top five analyst downgrades
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

BA Boeing
$178.45 /

+5.225 (+3.02%)

Hot Stocks
Harte Hanks trading halted, news pending  17:22
07/10/20
07/10
17:22
07/10/20
17:22
HHS

Harte-Hanks

$2.75 /

-0.22 (-7.41%)

 
ShowHide Related Items >><<
HHS Harte-Hanks
$2.75 /

-0.22 (-7.41%)

Syndicate
Innovation Pharmaceuticals files $60M mixed securities shelf  17:15
07/10/20
07/10
17:15
07/10/20
17:15
IPIX

Innovation Pharmaceuticals

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
IPIX Innovation Pharmaceuticals
$0.00 /

+ (+0.00%)

Periodicals
Foxconn plans to invest $1B to expand factory in southern India, Reuters says » 17:15
07/10/20
07/10
17:15
07/10/20
17:15
HNHPF

Hon Hai Precision

$0.00 /

+ (+0.00%)

, AAPL

Apple

$383.56 /

+0.78 (+0.20%)

Foxconn (HNHPF) intends…

Foxconn (HNHPF) intends to invest up to $1B to expand a plant in southern India where the company assembles Apple (AAPL) iPhones, Reuters' Sankalp Phartiyal and Yimou Lee report, citing two sources. The plan is part of a quiet and gradual production shift by Apple away from China as it navigates disruptions from a trade dispute between the U.S. and Beijing as well as the COVID-19 crisis, the authors note. "There's a strong request from Apple to its clients to move part of the iPhone production out of China," one of the sources with direct knowledge of the matter told Reuters. Reference Link

ShowHide Related Items >><<
HNHPF Hon Hai Precision
$0.00 /

+ (+0.00%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

HNHPF Hon Hai Precision
$0.00 /

+ (+0.00%)

02/24/20 Morgan Stanley
Hon Hai Precision upgraded to Overweight from Equal Weight at Morgan Stanley
AAPL Apple
$383.56 /

+0.78 (+0.20%)

07/09/20 Nomura Instinet
Nomura says Apple iPhone shipments in China pressured by 5G models in June
07/08/20 Deutsche Bank
'Nervous' Deutsche Bank raises Apple price target to $400 from $380
07/07/20 Raymond James
Apple price target raised to $400 from $340 at Raymond James
07/06/20 Loop Capital
Apple's build plan update negates speculation of cut, says Loop Capital
AAPL Apple
$383.56 /

+0.78 (+0.20%)

HNHPF Hon Hai Precision
$0.00 /

+ (+0.00%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

HNHPF Hon Hai Precision
$0.00 /

+ (+0.00%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

AAPL Apple
$383.56 /

+0.78 (+0.20%)

Hot Stocks
NuZee appoints Travis Gorney CMO, CFO Shanoop Kothari also named COO » 17:14
07/10/20
07/10
17:14
07/10/20
17:14
NUZE

NuZee

$14.50 /

-1.5 (-9.38%)

NuZee announced changes…

NuZee announced changes in senior management's duties. As part of these changes, Masateru Higashida, the company's CEO, will add the title of president and will directly oversee the company's three international subsidiaries. Shanoop Kothari will continue his duties as the company's CFO but has also been named as the company's COO and will lead the company's production efforts and direct to consumer channels in the U.S. Travis Gorney, will become the company's CMO and VP with the primary role of establishing and managing a sales team focused on adoption of single serve pour over coffee by major U.S. coffee brands. Both Kothari and Gorney will continue to report to Higashida.

ShowHide Related Items >><<
  • 19
    Jun
Periodicals
Texas COVID-19 cases rise 4.2%, Bloomberg reports » 17:03
07/10/20
07/10
17:03
07/10/20
17:03
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$317.65 /

+3.22 (+1.02%)

The new spike exceeds the…

The new spike exceeds the 7-day average of 3.9%, according to Bloomberg.

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$317.65 /

+3.22 (+1.02%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Periodicals
Amazon says email about TikTok sent in error, NY Times says » 17:01
07/10/20
07/10
17:01
07/10/20
17:01
AMZN

Amazon.com

$3,204.06 /

+19.57 (+0.61%)

In response to reports…

In response to reports that it told employees to delete TikTok from their phones for security reasons, Amazon has said that the email sent to employees "was sent in error," the New York Times' Karen Weise reports. "There is no change to our policies right now with regard to TikTok," the company said, according to Weise. Reference Link

ShowHide Related Items >><<
AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

07/10/20 Citi
Amazon.com price target raised to $3,550 from $2,700 at Citi
07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/09/20 Credit Suisse
Consumer survey highlights good initial interest in Walmart+, says Credit Suisse
07/08/20 Morgan Stanley
Walmart membership plan seems geared at protecting grocery, says Morgan Stanley
AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

AMZN Amazon.com
$3,204.06 /

+19.57 (+0.61%)

Conference/Events
CytoSorbents to host conference call » 16:42
07/10/20
07/10
16:42
07/10/20
16:42
CTSO

CytoSorbents

$10.15 /

+0.04 (+0.40%)

Conference call to…

Conference call to discuss the use of CytoSorb for antithrombotic drug removal will be held on July 13 at 11 am. Webcast Link

ShowHide Related Items >><<
CTSO CytoSorbents
$10.15 /

+0.04 (+0.40%)

CTSO CytoSorbents
$10.15 /

+0.04 (+0.40%)

06/02/20 B. Riley FBR
CytoSorbents gaining relevance as COVID-19 treatment, says B. Riley FBR
05/14/20 B. Riley FBR
CytoSorbents label expansion could significantly expand use, says B. Riley FBR
05/06/20 B. Riley FBR
B. Riley boosts CytoSorbents target, says Portola deal highlights value
03/25/20 Dawson James
CytoSorbents being used for COVID-19 in Italy, China, says Dawson James
CTSO CytoSorbents
$10.15 /

+0.04 (+0.40%)

CTSO CytoSorbents
$10.15 /

+0.04 (+0.40%)

CTSO CytoSorbents
$10.15 /

+0.04 (+0.40%)

Hot Stocks
Ra Capital reports 10.8% passive stake in Vaxcyte » 16:35
07/10/20
07/10
16:35
07/10/20
16:35
PCVX

Vaxcyte

$29.20 /

-0.49 (-1.65%)

In a regulatory filing,…

In a regulatory filing, Ra Capital Management disclosed a 10.8% stake in Vaxcyte, which represents about 5.49M shares. The filing does not allow for activism.

ShowHide Related Items >><<
PCVX Vaxcyte
$29.20 /

-0.49 (-1.65%)

07/07/20
Fly Intel: Top five analyst initiations
07/07/20 BofA
Vaxcyte initiated with a Buy at BofA
07/07/20 Jefferies
Vaxcyte initiated with a Buy at Jefferies
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
  • 12
    Jun
PCVX Vaxcyte
$29.20 /

-0.49 (-1.65%)

Earnings
Shaw Communications reports Q2 EPS C$35c vs. C$43c last year » 16:34
07/10/20
07/10
16:34
07/10/20
16:34
SJR

Shaw Communications

$16.55 /

+0.365 (+2.26%)

Reports Q2 revenue…

Reports Q2 revenue C$1.31B vs. C$1.32B last year. The company CEO Brad Shaw states: "While we continue to navigate through a period of widespread uncertainty, the solid performance of our business underscores the resilient and critical nature of the services we provide to our customers. Although subscriber activity was subdued during the quarter, primarily due to Canadians staying home to restrict the spread of COVID-19, the financial performance of the company was excellent. Throughout this challenging and unprecedented time, we are proud of the strength of our facilities-based networks, which are not just the core of our digital infrastructure - they are the backbone of our social and economic well-being. We have invested billions on building and improving our network and services and the benefits of these investments have never been more critical for Canadians during this crisis. We have compassionate employees who continue to go above and beyond to help each other and our customers and we remain dedicated to maintaining the safety of our employees and customers as well as supporting the communities and businesses in which we operate. As the economy begins to re-open, we are confident that our robust broadband and wireless infrastructure will continue to play a vital role and drive our economic recovery."

ShowHide Related Items >><<
SJR Shaw Communications
$16.55 /

+0.365 (+2.26%)

SJR Shaw Communications
$16.55 /

+0.365 (+2.26%)

06/03/20 Canaccord
Shaw Communications price target raised to C$26 from C$25 at Canaccord
06/02/20 National Bank
Shaw Communications price target raised to C$27 from C$26 at National Bank
04/13/20 Canaccord
Canaccord keeps Buy rating on Shaw after 'encouraging comments' in Q2 report
03/18/20 RBC Capital
Shaw Communications price target lowered to C$25 from C$29 at RBC Capital
SJR Shaw Communications
$16.55 /

+0.365 (+2.26%)

SJR Shaw Communications
$16.55 /

+0.365 (+2.26%)

Syndicate
Kitov Pharmaceuticals files to sell 28.05M ADSs for holders  16:34
07/10/20
07/10
16:34
07/10/20
16:34
KTOV

Kitov Pharmaceuticals

$0.82 /

-0.0349 (-4.08%)

 
ShowHide Related Items >><<
KTOV Kitov Pharmaceuticals
$0.82 /

-0.0349 (-4.08%)

Syndicate
Equity Residential files to sell ordinary shares, debt securities  16:34
07/10/20
07/10
16:34
07/10/20
16:34
EQR

Equity Residential

$56.64 /

-0.06 (-0.11%)

 
ShowHide Related Items >><<
EQR Equity Residential
$56.64 /

-0.06 (-0.11%)

EQR Equity Residential
$56.64 /

-0.06 (-0.11%)

07/07/20 Argus
Equity Residential price target lowered to $70 from $90 at Argus
06/29/20 Scotiabank
Scotiabank double downgrades Equity Residential on urban exposure
06/29/20 Scotiabank
Equity Residential downgraded to Underperform from Outperform at Scotiabank
05/18/20 BofA
BofA upgrades Camden Property to Buy, cuts Equity Residential, Aimco
EQR Equity Residential
$56.64 /

-0.06 (-0.11%)

EQR Equity Residential
$56.64 /

-0.06 (-0.11%)

Conference/Events
Celcuity to hold a conference call » 16:34
07/10/20
07/10
16:34
07/10/20
16:34
CELC

Celcuity

$5.89 /

-0.41 (-6.51%)

Conference call to review…

Conference call to review Celcuity's first test for ovarian cancer patients will be held on July 13 at 1 pm. Webcast Link

ShowHide Related Items >><<
CELC Celcuity
$5.89 /

-0.41 (-6.51%)

05/18/20 Craig-Hallum
Celcuity assumed with a Buy at Craig-Hallum
05/11/20 Craig-Hallum
Celcuity assumed with a Buy at Craig-Hallum
05/08/20 H.C. Wainwright
Celcuity price target lowered to $11 from $19 at H.C. Wainwright
Syndicate
Can-Fite BioPharma files to sell 96.7M ordinary shares for holders » 16:33
07/10/20
07/10
16:33
07/10/20
16:33
CANF

Can-Fite BioPharma

$1.83 /

-0.015 (-0.81%)

Represented by 3,224,566…

Represented by 3,224,566 American Depositary Shares.

ShowHide Related Items >><<
CANF Can-Fite BioPharma
$1.83 /

-0.015 (-0.81%)

CANF Can-Fite BioPharma
$1.83 /

-0.015 (-0.81%)

10/31/19 H.C. Wainwright
Can-Fite BioPharma price target raised to $5 from $3 at H.C. Wainwright
Hot Stocks
GSE Systems discloses notice of Nasdaq listing non-compliance » 16:32
07/10/20
07/10
16:32
07/10/20
16:32
GVP

GSE Systems

$1.00 /

-0.035 (-3.38%)

GSE Systems announced…

GSE Systems announced that it received a notice letter dated July 8, 2020 from the Listing Qualifications Department of The Nasdaq Stock Market LLC stating, that as a result of the company's failure to timely file its Quarterly Report on Form 10-Q for the three months ended March 31, 2020, the company is not in compliance with Nasdaq's Listing Rule 5250(c)(1). Nasdaq stated in its notification that the Company has 60 calendar days, or until September 6, 2020, to submit a plan to regain compliance. The Company intends to submit a plan of compliance on or before the September 6, 2020 deadline.

ShowHide Related Items >><<
GVP GSE Systems
$1.00 /

-0.035 (-3.38%)

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:31
07/10/20
07/10
16:31
07/10/20
16:31
GILD

Gilead

$76.35 /

+1.68 (+2.25%)

, NFLX

Netflix

$548.56 /

+40.65 (+8.00%)

, AMZN

Amazon.com

$3,200.55 /

+16.06 (+0.50%)

, WKHS

Workhorse Group

$15.18 /

-0.88 (-5.48%)

, APO

Apollo Global

$50.10 /

+0.15 (+0.30%)

, GBX

Greenbrier

$25.07 /

+3.325 (+15.29%)

, SHYF

Shyft Group

$16.90 /

+2.1 (+14.19%)

, BYND

Beyond Meat

$135.04 /

-6.09 (-4.32%)

, FSLY

Fastly

$94.98 /

-7.69 (-7.49%)

, RXT

Rackspace Technology

$0.00 /

+ (+0.00%)

Stock futures were weaker…

Open Full Text

ShowHide Related Items >><<
WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

SHYF Shyft Group
$16.90 /

+2.1 (+14.19%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

GILD Gilead
$76.35 /

+1.68 (+2.25%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

FSLY Fastly
$94.98 /

-7.69 (-7.49%)

BYND Beyond Meat
$135.04 /

-6.09 (-4.32%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

AMZN Amazon.com
$3,200.55 /

+16.06 (+0.50%)

GILD Gilead
$76.35 /

+1.68 (+2.25%)

07/10/20 Piper Sandler
Gilead's remdesivir data 'directionally positive,' says Piper Sandler
07/10/20 Stifel
Galapagos downgraded to Hold from Buy at Stifel
06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
NFLX Netflix
$548.56 /

+40.65 (+8.00%)

07/10/20 Goldman Sachs
Netflix price target raised to $670 from $540 at Goldman Sachs
07/10/20 Piper Sandler
Piper search index suggests inline Q2 sub results for Netflix
07/09/20 JPMorgan
JPMorgan raises Netflix sub addition estimate above Q2 guidance
07/08/20 Stifel
Netflix price target raised to $500 from $460 at Stifel
AMZN Amazon.com
$3,200.55 /

+16.06 (+0.50%)

07/10/20 Citi
Amazon.com price target raised to $3,550 from $2,700 at Citi
07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/09/20 Credit Suisse
Consumer survey highlights good initial interest in Walmart+, says Credit Suisse
07/08/20 Morgan Stanley
Walmart membership plan seems geared at protecting grocery, says Morgan Stanley
WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

07/09/20
Fly Intel: Top five analyst downgrades
07/09/20 Colliers
Workhorse Group downgraded to Neutral from Buy at Colliers
07/09/20 Colliers
Workhorse Group downgraded to Neutral from Buy at Colliers
07/01/20 BTIG
Workhorse Group price target raised to $26 from $10 at BTIG
APO Apollo Global
$50.10 /

+0.15 (+0.30%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

04/28/20 Susquehanna
Greenbrier downgraded to Negative from Neutral at Susquehanna
04/08/20 KeyBanc
Greenbrier price target lowered to $30 from $38 at KeyBanc
01/14/20 Wells Fargo
Greenbrier downgraded to Underweight from Equal Weight at Wells Fargo
11/08/19 Susquehanna
Greenbrier downgraded to Neutral from Positive at Susquehanna
SHYF Shyft Group
$16.90 /

+2.1 (+14.19%)

BYND Beyond Meat
$135.04 /

-6.09 (-4.32%)

07/10/20
Fly Intel: Top five analyst initiations
07/10/20 Citi
Citi starts Beyond Meat with Sell, sees 15% share downside
07/10/20 Citi
Beyond Meat initiated with a Sell at Citi
07/09/20 Bernstein
Beyond Meat price target raised to $133 from $118 at Bernstein
FSLY Fastly
$94.98 /

-7.69 (-7.49%)

07/10/20
Fly Intel: Top five analyst downgrades
07/10/20 Craig-Hallum
Fastly downgraded to Hold from Buy at Craig-Hallum
07/10/20 BofA
Fastly double-downgraded to Underperform from Buy at BofA
07/10/20 BofA
Fastly downgraded to Underperform from Buy at BofA
RXT Rackspace Technology
$0.00 /

+ (+0.00%)

WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

GILD Gilead
$76.35 /

+1.68 (+2.25%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

FSLY Fastly
$94.98 /

-7.69 (-7.49%)

BYND Beyond Meat
$135.04 /

-6.09 (-4.32%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

AMZN Amazon.com
$3,200.55 /

+16.06 (+0.50%)

  • 21
    May
  • 26
    Nov
  • 01
    Aug
WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

GILD Gilead
$76.35 /

+1.68 (+2.25%)

BYND Beyond Meat
$135.04 /

-6.09 (-4.32%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

AMZN Amazon.com
$3,200.55 /

+16.06 (+0.50%)

WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

GILD Gilead
$76.35 /

+1.68 (+2.25%)

GBX Greenbrier
$25.07 /

+3.325 (+15.29%)

FSLY Fastly
$94.98 /

-7.69 (-7.49%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

AMZN Amazon.com
$3,200.55 /

+16.06 (+0.50%)

WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

SHYF Shyft Group
$16.90 /

+2.1 (+14.19%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

GILD Gilead
$76.35 /

+1.68 (+2.25%)

FSLY Fastly
$94.98 /

-7.69 (-7.49%)

BYND Beyond Meat
$135.04 /

-6.09 (-4.32%)

APO Apollo Global
$50.10 /

+0.15 (+0.30%)

AMZN Amazon.com
$3,200.55 /

+16.06 (+0.50%)

NFLX Netflix
$548.56 /

+40.65 (+8.00%)

AMZN Amazon.com
$3,200.55 /

+16.06 (+0.50%)

Options
Preliminary option volume of 30.1M today » 16:30
07/10/20
07/10
16:30
07/10/20
16:30

Preliminary option volume…

Preliminary option volume of 30.1M today is 2% above recent average. Calls led puts 18.38M to 11.70M.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.